Nina White

Nina is a Chartered Patent Attorney and European Patent Attorney and Head of the Biotechnology and Life Sciences practice group.

Nina specialises in patent work in the biotechnology and pharmaceutical fields, including both biologics and small-molecule pharmaceuticals, with a particular focus on therapeutic antibodies. She also has technical expertise in the fields of antibody engineering, cell culture methods, antibody purification and formulation, biomarkers, companion diagnostics, immunoassays, RNAi, probiotics and nutritional products.

A large part of Nina’s practice relates to post-grant opposition and appeal proceedings at the European Patent Office, and also IP due diligence work, principally for multi-national pharmaceutical clients. Nina also has extensive experience of working closely with start-up companies, SMEs and University spin-outs, providing a full range of commercially-focused patent services including: drafting and worldwide prosecution of patent applications, freedom-to-operate advice, IP due diligence, patent strategy and portfolio management, including patent term extension (SPCs).

Nina has been recognised in the world’s leading IP practitioners Who’s Who Legal List 2021, and in Managing Intellectual Property IP Stars 2021.  She was also listed in the JUVE Patents UK rankings, 2021 as a Patent Attorney with specialist technical expertise in Pharma and Biotechnology.

Nina has an MA in Biochemistry and a DPhil in Molecular Biology, both from the University of Oxford. Her doctoral research, carried out at the Institute of Molecular Medicine, investigated expression of the human cystic fibrosis gene. She also has a postgraduate certificate in Intellectual Property Law from Queen Mary & Westfield College, University of London.

Nina was awarded the Chartered Institute of Patent Agents Ballantyne Prize, for her performance in the CIPA final examinations.